Lack of evidence for mutations or deletions in the CDKN2A/p16 and CDKN2B/p15 genes of Brazilian neuroblastoma patients

Brazilian Journal of Medical and Biological Research

Volumn 37, Issue 11, 2004, Pages 1683-1687

  Bassi, C L ^a   Martelli, L ^a   Cipolotti, R ^a   Scrideli, C A ^a   Defavery R ^a   Tone, L G ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Deletion; Mutation; Neuroblastoma; p15 gene; p16 gene

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR; PROTEIN P15; PROTEIN P16;

ADOLESCENT; ARTICLE; BRAZIL; CANCER MORTALITY; CANCER STAGING; CHILD; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; DNA SEQUENCE; EXON; FEMALE; GENE DELETION; GENE FREQUENCY; GENE LOCATION; GENE MUTATION; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; INFANT; MALE; MOLECULAR MECHANICS; NEUROBLASTOMA; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROTEIN FUNCTION; SEQUENCE ANALYSIS; TUMOR CELL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

EID: 9244241061     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2004001100014     Document Type: Article

References (21)

1. Castleberry RP (1997). Biology and treatment of neuroblastoma. Pediatric Clinics of North America, 44: 919-937.
2. Hospital do Câncer A.C. Camargo. Registro Hospitalar do Câncer Pediátrico - 1988 & 1994 (1999). Monografias do Registro Hospitalar do Câncer. Centro cle Tratamento e Pesquisa do Hospital do Câncer A.C. Camargo, São Paulo, SP, Brazil.
3. Takita J, Hayashi Y, Kohno T, Yamaguchi N, Hanada R, Yamamoto K & Yokota J (1997). Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in neuroblastoma. Cancer Research, 57: 907-912.
4. INK4B is a potential effector of TGFβ-induced cell cycle arrest. Nature, 371: 257-261.
5. Serrano M, Hannon J & Beach D (1993). A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature, 366: 704-707.
6. Brodeur GM, Seeger RC, Barrett A et al. (1988). International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. Journal of Clinical Oncology, 6: 1874-1881.
7. INK4B deletions in childhood acute lymphoblastic leukemias containing distinct EA2 translocations. Leukemia, 12: 1417-1421.
8. Lemos JAR, Defavery R, Scrideli CA & Tone LG (1999). Alterations of the p16 gene in Brazilian children with acute lymphoblastic leukemia. Medical and Pediatric Oncology, 33: 223 (Abstract).
9. INK4B/MTS2 in Brazilian children with acute lymphoblastic leukemia (ALL). Medical and Pediatric Oncology, 33: 268 (Abstract).
10. Beltinger CP, White PS, Sulman EP, Maris JM & Brodeur GM (1995). No CDKN2 mutations in neuroblastomas. Cancer Research, 55: 2053-2055.
11. Castresana JS, Gomez L, Garcia-Miguel P, Cueizan A & Pestana A (1997). Mutational analysis of the p16 gene in human neuroblastomas. Molecular Carcinogenesis, 18: 129-133.
12. Iolascon A, Giordan L, Moretti A, Tonini GP, LoCunsolo C, Mastropietro S, Borrielo A & Ragione FD (1998). Structural and functional analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B and CDKN2C) in neuroblastoma. Pediatric Research, 43: 139-144.
13. Takita J, Hayashi Y, Kohno T, Shiseiki M, Yamaguchi N, Hanada R, Yamamoto K & Yokota J (1995). Allelotype of neuroblastoma. Oncogene 11: 1829-1834.
14. Easton J, Wei T, Lahti JM & Kidd VJ (1998). Disruption of the cyclin D/cyclin-dependent kinase/INK4/retinoblastoma protein regulatory pathway in human neuroblastoma. Cancer Research, 58: 2624-2632.
15. 1 cell cycle-regulatory pathway in neuroblastoma. International Journal of Cancer, 80: 145-154.
16. Chim CS, Liang R & Kwong YL (2002). Hypermethylation of gene promoters in hematological neoplasia. Hematological Oncology, 20: 167-176.
17. Takita J, Hayashi Y, Nakajima T, Adachi J, Tanaka T, Yamaguchi N, Ogawa Y, Hanada F, Yamamoto K & Yokota J (1998). The p16 (CDKN2A) gene is involved in the growth of neuroblastoma cells and its expression is associated with prognosis of neuroblastoma patients. Oncogene, 17: 3137-3143.
18. Herman JG, Merlo A, Mao L, Mao L, Lapidus RG, Issa JPJ, Davidson NE, Sidransky D & Baylin SB (1995). Inactivation of the CDKN2/ p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Research, 55: 4525-4530.
19. Omura-Minamisawa M, Diccianni MB, Chang RC, Batova A, Bridgeman LJ, Schiff J, Cohn SL, London WB & Yu AL (2001). P16 14ARF cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease. Clinical Cancer Research, 7: 3481-3490.
20. Giordani L, Iolascon A, Servedio V, Mazzocco K, Longo L & Tonini GP (2002). Two regions of deletion in 9p22-24 in neuroblastoma are frequently observed in favorable tumors. Cancer Genetics and Cytogenetics, 135: 42-47.
21. Obana K, Yang HW, Piao HY et al. (2003). Aberrations of p16INK4A, p14ARF and p15INK4B genes in pediatric solid tumors. International Journal of Oncology, 23: 1151-1157.